Interventional Radiology Products Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 30.60 Bn

Forecast Year, 2035

USD 63.66 Bn

CAGR, 2026 - 2035

7.60%

Report Coverage

Global

What is the Interventional Radiology Products Market Size in 2026?

The global interventional radiology products market size accounted for USD 30.60 billion in 2025 and is predicted to increase from USD 32.93 billion in 2026 to approximately USD 63.66 billion by 2035, expanding at a CAGR of 7.60% from 2026 to 2035. The market is driven by the rising adoption of minimally invasive procedures, advancements in imaging technologies, and the increasing prevalence of chronic diseases.

Key Takeaways

• North America led the market with a major share of 38% in 2025.
• Asia Pacific is expected to grow at the fastest CAGR of 8.0% during the forecast period.
• By product type, the stents segment held the largest market share of 32% in 2025.
• By product type, the catheters segment is expected to expand with the highest CAGR of 6.2% during the forecast period.
• By procedure type, the angioplasty segment dominated the market with a share of 34% in 2025.
• By procedure type, the embolization segment is expected to rise with the fastest CAGR of 6.4% during the forecast period.
• By application, the cardiology segment led the market with a share of 30% in 2025.
• By application, the oncology segment is expected to grow at a significant rate in the coming years.
• By end-user, the hospitals segment led the market with a share of 56% in 2025.
• By end-user, the ambulatory surgical centers segment is expected to expand with the highest CAGR of 6.8% during the forecast period.
• By imaging modality, the fluoroscopy/angiography segment dominated the market with a share of 42% in 2025.
• By imaging modality, the CT-guided imaging segment is expected to grow with the fastest CAGR of 6.5% during the forecast period.

What are Interventional Radiology (IR) Products?

Interventional radiology (IR) products are high-quality medical devices used in minimally invasive, image-guided procedures to detect and treat various diseases. These products include catheters, stents, guidewires, embolization devices, angioplasty balloons, and biopsy needles that are guided by advanced imaging technologies such as fluoroscopy, CT, ultrasound, or MRI. They enable precise treatment of cardiovascular diseases, cancer, and vascular disorders by reducing the surgical risks and recovery time. These products are widely used in hospitals and specialized clinics to support advanced diagnostic and therapeutic procedures. The market is expected to grow significantly with the expansion of the healthcare sector worldwide and rising surgical procedures.

How is AI Influencing the Interventional Radiology Products Market?

Artificial intelligence is transforming the interventional radiology products market by enhancing imaging accuracy, enabling real-time procedure guidance, and improving workflow efficiency, which leads to safer, faster, and more precise minimally invasive treatments. AI initiates the fusion of pre-procedural 3D data (from CT/MRI) into real-time 2D fluoroscopy for guiding catheters and needles with superior precision. In addition, AI-enabled ultrasound and CT systems can automatically track needle insertion sites, detect needle tips, and analyze anatomical structures, such as tumors and vessels, to enhance the capabilities of healthcare professionals.

• In September 2025, GE Healthcare launched the Voluson Performance series ultrasound systems. These ultrasound systems are integrated with AI to assist physicians with efficient care across a wide range of surgical procedures.

Interventional Radiology Products Market Trends

• Collaborations: Several medical device manufacturing companies are collaborating with pharma brands to develop advanced interventional radiology systems. For instance, in September 2025, Cook Medical collaborated with Siemens Healthineers. This collaboration aims to develop a new range of interventional MRI suits for the end-users.
• Product Launches: Numerous surgical product manufacturers are engaged in launching a wide range of interventional radiology items to hold their dominant position in the industry. For instance, in May 2025, Johnson & Johnson launched an ultrasound catheter. This catheter delivers high-quality images, peak manoeuvrability, and seamless Carto 3 System integration in cardiac ablation procedures.
• Business Expansions: Market players are investing rapidly in opening new production centers to increase the manufacturing of interventional radiology products. For instance, in July 2025, Varex Imaging established a manufacturing unit in Andhra Pradesh, India. This production facility was inaugurated to increase the production of interventional cardiology products to cater to the needs of India.
• Opening New Hospitals: Governments of several countries are constantly engaged in establishing new public hospitals to deliver high-quality treatment to the people. For instance, in June 2025, the government of Tamil Nadu, India, announced to invest around Rs 197.81 crores. This investment is made to open a Government Pentland Multi-Specialty Hospital in Vellore.
• High Prevalence of Chronic Disorders: The growing cases of cardiovascular diseases and cancers in different parts of the world have increased the demand for radiology equipment. According to the American Cancer Society, around 324580 new breast cancer cases are expected to be diagnosed across this region in 2026.

Market Scope

Segment Insights

Product Type Insights

Why Did the Stents Segment Dominate the Interventional Radiology Products Market?

The stents segment dominated the market with a major share of 32% in 2025 due to the surging adoption of minimally invasive surgical procedures to treat vascular and non-vascular blockages. Stents are used for restoring blood flow in obstructed and narrowed vessels for the treatment of coronary artery disease and peripheral artery disease. Additionally, continuous innovations in drug-eluting and bioresorbable stents enhance patient outcomes, further strengthening their market leadership.

The catheters segment is expected to grow at the highest CAGR of 6.2% during the forecast period. This is mainly due to their crucial role in a wide range of therapeutic and diagnostic procedures. Catheters find application in image-guided interventions to access internal organs and blood vessels with minimal surgical invasion.

Procedure Type Insights

What Made Angioplasty the Leading Segment in the Interventional Radiology Products Market?

The angioplasty segment led the market with a share of 34% in 2025. This is mainly due to the increasing adoption of angioplasty procedures for treating vascular disorders. Angioplasty is commonly preferred to restore blood flow in arteries by the insertion of balloon catheters and stents. This surgical procedure helps in reducing hospital stays, low complication rates, and quick patient recovery. Additionally, advancements in balloon catheters, stents, and imaging guidance have improved procedural success and patient outcomes, further strengthening its market dominance.

The embolization segment is expected to grow with the fastest CAGR of 6.4% during the forecast period due to its surging use in treating tumors, vascular malformations, and hemorrhages with minimally invasive techniques. The embolization process involves the blockage of blood vessels using advanced materials, such as coils, liquid agents, and adhesive particles, to control bleeding. These surgical techniques are further used in the management of several diseases, including uterine fibroids, arteriovenous malformations, and prostate cancers. Additionally, innovations in embolic materials and delivery devices are improving safety and efficacy, further boosting the segment's market growth.

Application Insights

What Made Cardiology the Leading Segment in the Market?

The cardiology segment led the interventional radiology products market while holding a major share of 30% in 2025 and is expected to grow at the fastest rate in the coming years. This is due to the increasing adoption of minimally invasive surgical procedures for the treatment of cardiac disorders. Interventional radiology procedures are widely adopted in the cardiology field for diagnosing and treating vascular blockages by using image-guided technologies.

The oncology segment is expected to grow at a significant rate throughout the projection period, owing to the surging prevalence of cancers in several nations, such as the U.S., Germany, and China. Interventional radiology technologies play an important role in the oncology field, enabling targeted therapies to treat tumors with superior precision, along with minimizing damage to healthy cells.

Imaging Modality Insights

Why Did the Fluoroscopy/Angiography Segment Dominate the Interventional Radiology Products Market?

The fluoroscopy/angiography segment dominated the interventional radiology products market with the largest share of 42% in 2025. This is mainly due to its prominent role in guiding precise and image-based medical procedures. These imaging techniques allow doctors to visualize internal organs in real-time to place devices accurately during minimally invasive procedures.

Interventional Radiology Products Market Share, By Imaging Modality, 2025 (%)

The CT-guided imaging segment is expected to expand with the fastest CAGR of 6.5% during the forecast period, owing to its superior diagnostic accuracy and its ability to deliver detailed anatomical visualization during surgeries. CT-guided imaging allows doctors to locate tumors, lesions, and internal abnormalities to place several devices, including biopsy needles and catheters.

End-User Insights

Why Did the Hospitals Segment Dominate the Interventional Radiology Products Market?

The hospitals segment dominated the market for interventional radiology products with the largest share of 56% in 2025. This is because of the availability of advanced technologies such as AI and IoT in modern hospitals, as well as the increasing preference of patients to visit hospitals for surgeries. Governments of several countries are partnering with healthcare device companies to deploy high-quality imaging systems in public hospitals to enhance treatment access.

Interventional Radiology Products Market Share, By End-User, 2025 (%)

The ambulatory surgical centers segment is expected to grow with the highest CAGR of 6.8% during the forecast period. This is mainly due to the surging number of minimally invasive procedures performed in ambulatory surgical centers. These centers are designed to deliver specialized image-guided treatments by lowering hospital stays and lessening procedure costs.

Regional Insights

North America Interventional Radiology Products Market Size and Growth 2026 to 2035

The North America interventional radiology products market size is estimated at USD 11.63 billion in 2025 and is projected to reach approximately USD 24.51 billion by 2035, with a 7.74% CAGR from 2026 to 2035.

Why Did North America Dominate the Interventional Radiology Products Market?

North America dominated the interventional radiology products market with a share of 38% in 2025 due to the deployment of advanced equipment in hospitals, coupled with the rapid investments in the pharmaceutical sector by public and private companies. The region benefits from the presence of prominent market players, such as Abbott Laboratories, AngioDynamics, Inc, Stryker Corporation, and Teleflex Inc. The surging cases of prostate cancer are also contributing to the development of the market. In addition, the increasing preference of doctors to adopt minimally invasive surgical procedures, along with the presence of well-established healthcare infrastructure in the U.S. and Canada, has driven the market growth.

• In February 2025, Teleflex acquired Biotronik's vascular intervention business. This acquisition aims to expand Teleflex's IR products portfolio across the U.S.

U.S. Interventional Radiology Products Market Size and Growth 2026 to 2035

The U.S. interventional radiology products market size is calculated at USD 8.72 billion in 2025 and is expected to reach nearly USD 18.50 billion in 2035, accelerating at a strong CAGR of 7.81% between 2026 and 2035.

U.S. Interventional Radiology Products Market Analysis

The U.S. is the major contributor to the interventional radiology products industry in North America, owing to the increasing number of cancer research institutes, as well as the surging adoption of FDA-approved medical devices by healthcare professionals. The growing healthcare expenditure, along with the rapid establishment of diagnostic centers across the country, is accelerating market growth.

How is the Opportunistic Rise of Asia Pacific in the Market?

Asia Pacific is expected to expand with the highest CAGR of 8.0% during the forecast period, owing to the increasing cases of cardiovascular diseases in China and India, along with surging research and activities associated with medical devices. The growing focus of the government on establishing new hospitals, as well as the rise in the number of ambulatory surgical centers, has played a vital role in shaping the landscape of the market. This region is home to various healthcare device companies, including Terumo Corporation, Hitachi Medical Corporation, and Fujifilm Holdings Corporation, coupled with the increasing adoption of AI-enabled MRI systems in specialty clinics, which is likely to boost the industrial landscape.

• In October 2025, Terumo Interventional Systems launched the Opuswave Imaging System. This imaging system integrates OFDI and IVUS into a single catheter to reduce procedural time in the treatment of coronary artery disease.

China Interventional Radiology Products Market Analysis

China leads the interventional radiology products industry in Asia Pacific, owing to the increasing consumer interest in visiting hospitals on regular intervals, along with the deployment of advanced diagnostic systems in modern hospitals. The increasing proliferation of medical device startups, coupled with the rise in the number of neurology patients, has contributed to the development of the industry.

Interventional Radiology Products Market Supply Chain Analysis

Interventional Radiology Products Market Companies

• Medtronic plc
• Boston Scientific Corporation
• Abbott Laboratories
• Becton, Dickinson and Company (BD)
• Terumo Corporation
• Stryker Corporation
• Cook Medical
• Teleflex Incorporated
• Biosensors International Group
• Meril Life Sciences
• BIOTRONIK SE & Co. KG
• AngioDynamics, Inc.
• Cardinal Health
• B. Braun Melsungen AG
• Penumbra, Inc.

Segments Covered in the Report

By Product Type

• Stents
• Catheters
• Guidewires
• Angioplasty Balloons
• Embolization Devices
• Others (IVC Filters, Biopsy Needles, Accessories)

By Procedure Type

• Angioplasty
• Angiography
• Embolization
• Thrombolysis
• Biopsy & Drainage

By Application

• Cardiology
• Oncology
• Gastroenterology
• Neurology
• Urology & Nephrology
• Orthopedics

By End-User

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

By Imaging Modality

• Fluoroscopy/Angiography
• CT-Guided Imaging
• Ultrasound
• MRI

By Region

• North America
• Latin America
• Europe
• Asia-pacific
• Middle and East Africa